Theravance Biopharma Aktie
16,40
EUR
+0,10
EUR
+0,61
%
19,54
USD
+0,15
USD
+0,77
%
Werbung
Theravance Biopharma Aktie Analyse
| 16.06.17 | Theravance Biopharma Overweight | Cantor Fitzgerald | |
| 11.05.17 | Theravance Biopharma Buy | Needham & Company, LLC | |
| 21.12.16 | Theravance Biopharma Buy | Needham & Company, LLC |
Werbung
Werbung